Ripley94
24 Jun 2019
Share issue / fund raising ANG… Share Maiden suggestion 16 april @ 74p … placing since around 50 i think . thought she had said well funded ! Around 64p now
Good_money_after_bad
06 Aug 2018
Share issue / find raising Anyone know how many shares we may be able to buy at 50p in the latest round of fund raising and when it might happen ? Thanks
claude reins
04 Jun 2018
Re: Good RNS today Further to my last posting, the news on breast cancer couldn't be more encouraging - with from today, so they say, surgery + hormone therapy replacing surgery + chemo.........but only for early stage diagnoses......... and that is where Angle comes in. Angle's early diagnosis without physical biopsy goes hand in hand with the developments announced over the weekend, yet is at least as important. Just think of your partner being diagnosed early with a blood test, without the pain and suffering of a physical biopsy. Then if surgery isn't needed, she doesn't have to go through that to prove whether she needs to go onto this now new next stage of surgery for removal of the tumour, examination of the tumour, and then decision that she may be able to avoid chemo afterwards. That is what would want for my partner; I'm sure you would want the same. Angle is playing for those high stakes commercially, as well as offering a great health benefit too,
claude reins
04 Jun 2018
Good RNS today At first sight, 80+ recruited for 400 patient study doesnt seem very many, but 4 hospitals involved. Also the key information is when the results are expected - yes, H2, calendar 2018. Not far away. Things are moving, and I am really tempted to add, just when the standard SP fall comes along after a promising RNS. If people say 'jam tomorrow', yes it is a R&D company but with so much more than it had 18 months ago, and much more than 3 years ago, yet the SP over those 3 years has been 95p, 67p, 56p. Amazing!!!As I say, much further along the line now; possibility of having an important first with the FDA; critical area of activity - breast cancer - with important supporters - prostate work going on in parallel too; a series of VIP companies working with them on the marketing and distribution, as well as a big brother in Philips Healthcare. This SP going to go with a bang, probably quite soon after the end of 2018 if not before.See the following section from the RNSWhile enrolment of subjects into this study is under the control of the independent cancer centres and outside the Company's direct control, the progress reported today suggests that both the clinical study and the associated analytical studies will complete, as planned, in H2 CY 2018. ANGLE Founder and Chief Executive, Andrew Newland, commented:"We are pleased to announce today that patient enrolment to date for our FDA study has been encouraging and we now have four leading US cancer centres actively recruiting subjects for the study. We continue to believe there is a tremendous opportunity for ANGLE to secure the first ever FDA clearance for a platform that captures and harvests intact circulating tumor cells from patient blood for subsequent analysis. This would be a key step in establishing the Parsortix system as the system of choice for CTC liquid biopsy securing a leading position in the emerging multi-billion dollar liquid biopsy market."
Good money after bad
01 Jun 2018
Re: Here's we go again........ Probably....just sold a few of mine in the hope that I can buy them back after they drop below 50p. Hope I’m not wrong but if it does rocket I’m still overweight with Angl
iq999
01 Jun 2018
Re: Here's we go again........ Hope not just breaking even - its seem like we’ve been waiting forever for approvals of any sort and the dates keep slipping
millwallfan
01 Jun 2018
Here's we go again........ Is this another false dawn?????
millwallfan
23 May 2018
Increasingly Frustrated .. With this share. Seems to hold immense potential and under 120 .million shares in issue. Regular stream of ‘good news’ but no major upward shift in price. I have repeatedly asked on this board and directly on the company website but have never been able to get an answer to the fundamental question - once commercialised what will be the basis of the future income stream(s) - is it ‘oneoff’ per machine sold, lease income from machines and most critical of all will there be a ‘royalty’ fee ‘per test’ - providing long term and incremental income as the tests become (hopefully) the new ‘standard’ for establishing the best treatment per individual patient. Once adopted worldwide the potential is unlimited. The other key factor is the timeline for full medical approval. Anyone have any knowledge in regard to these points ????
claude reins
03 May 2018
Re: More good news. Mmm. Rarely seems to be reflected in the SP. Still the latest target seems to be around 100p. Just gotta hold in there.
autpaxautbellum
03 May 2018
More good news. Collaborations coming together.
Chicken Lips
19 Apr 2018
Re: News today This is a great company loads of potential, potential upswing in the SP. I got in but found the water a bit choppy for a PI (not that every share is swinging currently). I think this is one to watch and the news today is excellent but the initial surge has fallen back. Its surprising as you say with so few shares in play that the ups are not more sustained?
millwallfan
19 Apr 2018
News today Excellent USA exposure from independent experts. If the system can get first choice adoption in major countries with only 118 million shares in issue then hopefully we should now start to see some sustained growth.
viko
26 Mar 2018
Bca marketplace share look cheap Director buys,bikers target £2.30
Petet1
26 Mar 2018
Price Why are III reporting this as down this morning , when in fact it is up approx 16% ???
lipsey
26 Mar 2018
Great results I don't pretend to be an expert but this news today looks to be life changing for people with this kind of cancerI have held these shares for many many years lets hope this is good news for the share price now
